International NeuroAIDS: Prospects of HIV-1 associated neurological complications

Cell Research

Volumn 15, Issue 11-12, 2005, Pages 962-969

  Trujillo, J Roberto ^a   Jaramillo Rangel, Gilberto ^a   Ortega Martinez, Marta ^a   Penalva De Oliveira, Augusto C ^b,c   Vidal, Jose E ^b   Bryant, Joseph ^a   Gallo, Robert C ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

AIDS dementia complex; HIV 1 neurotropism; NeuroAIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FORECASTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNATIONAL COOPERATION; NEUROLOGIC DISEASE; REVIEW; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FORECASTING; HIV-1; HUMANS; INTERNATIONALITY; NERVOUS SYSTEM DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS; PNEUMOCYSTIS CARINII;

EID: 29244477840     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290374     Document Type: Review

References (86)

1. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305:1425-31.
2. Gallo RC, Sarin PS, Gelmann EP, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983; 220:865-7
3. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet 2004; 364:69-82.
4. Press office of Chinese Ministry of Health. The report of 2002 HIV/AIDS epidemic situation and the development of prevention & control in China. Beijing; February 2003.
5. Chinese Ministry of Health. The summary of HIV/AIDS of prevention and control in China (Chinese). Beijing; November 2002.
6. National Center for AIDS/STD Prevention and Control, Chinese Center for Disease Control and Prevention. Information on HIV/AIDS prevention and control. 2003; 12:212-5.
7. Center for Business and Government-Asia Programs. Kennedy School of Goverment, Harvard University. Novartis Foundation for Sustainable Development. Information for Health: The Harvard HIV/AIDS Initiative in China. December 2004.
8. Trujillo JR, Garcia-Ramos G, Novak IS, et al. Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:23-9.
9. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology 1989; 39:119-22.
10. An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol (Berl) 1999; 98:481-7.
11. Dougherty RH, Skolasky RL Jr, McArthur JC. Progression of HIV-associated dementia treated with HAART. AIDS Read 2002; 12:69-74.
12. Lanska DJ. Epidemiology of human immunodeficiency virus infection and associated neurologic illness. Semin Neurol 1999; 19:105-11.
13. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14:69-74.
14. Letendre SL, McCutchan JA, Childers ME, et al. Predictors of improvement in human immunodefiency virus-associated neurocognitive disorders during antiretroviral therapy. Ann Neurol, in press.
15. Strain M, Letendre S, Pillai S, et al. Genetic Composition of HIV-1 in CSF and plasma without treatment and during failing combination antiretroviral therapy. J Virol, in press.
16. Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10:573-85.
17. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38:755-62.
18. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 1994; 144:659-66.
19. Takahashi K, Wesselingh SL, Griffin DE, et al. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39: 705-11.
20. Wang TH, Donaldson YK, Brettle RP, Bell JE, Simmonds P. Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 2001; 75:11686-99.
21. Wiley CA. Polymerase chain reaction in situ hybridization opening Pandora's box? Ann Neurol 1996; 39:691-2.
22. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83:7089-93.
23. Ranki A, Nyberg M, Ovod V, et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9:1001-8.
24. Saito Y, Sharer LR, Epstein LG, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44:474-81.
25. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44:481-7.
26. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984; 312:767-8.
27. Maddon PJ, Dalgleish AG, McDougal JS, et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47:333-48.
28. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-7.
29. Alkhatib G, Combadiere C, Broder CC, et al. CC-CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-8.
30. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-48.
31. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661-6.
32. Doranz B, Rucker JJ, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85:1149-58.
33. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-73.
34. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385:645-9.
35. Cheng-Mayer C, Rutka JT, Rosenblum ML, et al. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci USA 1987; 84:3526-30.
36. Harouse JM, Kunsch C, Hartle HT, et al. CD4-independent infection of human neural cells by human immunodeficiency vir us type 1. J Virol 1989; 63:2527-33.
37. Li XL, Moudgil T, Vinters HV, Ho DD. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J Virol 1990; 64:1383-7.
38. Tateno M, Gonzalez-Scarano F, Levy JA. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci USA 1989; 86:4287-90.
39. Clapham PR, Weber JN, Whitby D, et al. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 1989; 337:368-70.
40. Zachar V, Spire B, Hirsch I, Chermann JC, Ebbesen P. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol 1991; 65:2102-7.
41. Stahmer I, Zimmer JP, Ernst M, et al. Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1). Eur J Immunol 1991, 21:1873-8.
42. Yahi N, Baghdiguian S, Moreau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol 1992; 66:4848-54.
43. Barboza A, Castro BA, Whalen M, et al. Infection of cultured human adrenal cells by different strains of HIV. AIDS 1992; 6:1437-43.
44. Cao YZ, Friedman-Kien AE, Huang YX, et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol 1990; 64:2553-9.
45. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253:71-4.
46. O'Brien WA, Koyanagi Y, Namazie A, et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990; 348:69-73.
47. Shioda T, Levy JA, Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991; 349:167-9.
48. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547-54.
49. Kuiken CL, de Jong JJ, Baan E, et al. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol 1992; 66:4622-7.
50. Trujillo JR, Wang WK, Lee TH, Essex M. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. Virology 1996; 217:613-7.
51. Trujillo EB, Trujillo JR, Brain JD. The common molecular virology of HIV-1 tropism in "HIV-1 wasting syndrome" and "AIDS dementia complex". Neurology 1997; 48:A94-5.
52. gag and env genes. J Virol 1997; 71:1272-80.
53. Korber BTM, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope glycoprotein of brain-derived sequences. J Virol 1994; 68:7467-81.
54. Shapshak P, Segal DM, Crandall KA, et al. Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses 1999; 15:811-20.
55. Ohagen A, Devitt A, Kunstman KJ, et al. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 2003; 77:12336-45.
56. Thompson KA, McArthur JC, Wesselingh SL. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 2001; 49:745-52.
57. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-94.
58. Thompson KA, Churchill MJ, Gorry PR, et al. Astrocyte specific viral strains in HIV dementia. Ann Neurol 2004; 56:873-7.
59. Chun TW, Finzi D, Margolick J, et al. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nature Med 1995; 1:1284-90.
60. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-8.
61. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-300.
62. Glynn SL, Yazdanian M. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci 1998; 87:306-10.
63. Lee CG, Gottesman MM, Cardarelli CO, et al. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998; 37:3594-601.
64. Masereeuw R, Jaehde U, Langemeijer MW, de Boer AG, Breimer DD. In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors. Pharm Res 1994; 11:324-30.
65. Cosenza MA, Zhao ML, Si Q, Lee SC. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 2003; 12:442-55.
66. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999; 13:1-22.
67. Sabri F, Titanji K, De Milito A, Chiodi F. Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection. Brain Pathol 2003; 13:84-94.
68. Lawrence DM, Durham LC, Schwartz L, et al. Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 2004; 78:7319-28.
69. Bell JE, Busuttil A, Ironside JW, et al. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993; 168:818-24.
70. Boni J, Emmerich BS, Leib SL, et al. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993; 43: 1813-7.
71. Pang S, Koyanagi Y, Miles S, et al. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990; 343:85-9.
72. Teo I, Veryard C, Barnes H, et al. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997; 71:2928-33.
73. Gildenberg PL, Langford L, Kim JH, Trujillo R. Stereotactic biopsy in cerebral lesions if AIDS. Acta Neurochir 1993; 58:68-70.
74. Ministério da Saúde do Brazil. 2005. Dados e Pesquisas em DST e AIDS. www.aids.gov.br
75. Madalosso G, Pellini AC, Vasconcelos MJ, et al. Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil. Rev Inst Med Trop Sao Paulo 2004; 46:199-202.
76. Fink MC, Penalva de Oliveira AC, Milagres EA, Vidal JE, Pannuti C. JC vírus DNA in cerebrospinal fluid samples from Brazilian aids patients with focal brain lesions without mass effect J Infect, in press.
77. Vidal JE, Oliveira AC, Dauar RF. Cerebral tuberculomas or tuberculous brain abscess: the dilemma continues. Clin Infect Dis 2005; 40:1072.
78. Vidal JE, Oliveira AC, Leite AG, et al. Tuberculous brain abscess in AIDS patients: report of three cases and literature review. Int J Infect Dis 2005; 9:201-7.
79. Vidal JE, Hernández AV, Oliveria AC, et al. Cerebral tuberculomas in AIDS patients: a forgotten diagnosis?. Arq Neuropsiquiatr 2004; 62:793-6.
80. Guimarães M. Temporal study in AIDS-associated disease in Brazil, 1980-1999. Cad Saude Publica 2000; 16:21-36.
81. Abgrall S, Rabaud C, Costagliola D, Clinical Epidemiology Group of the French Hospital Database on HIV. Incidence and risk factors for toxoplasmic encephalitis in human imunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001; 33:1747-55.
82. Vidal JE, Hernandez AV, de Oliveira AC, et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS 2005; 19:626-34.
83. Vidal JE, Colombo FA, de Oliveira AC, Focaccia R, Pereira-Chioccola VL. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol 2004; 42:4765-8.
84. Colombo FA, Vidal JE, Penalva de Oliveira AC, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol 2005; 43:5044-7.
85. Shankar SK, Mahadevan A, Satishchandra P, et al. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 2005; 121:468-88.
86. Reid W, Sadowska M, Denaro F, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 2001; 98:9271-9276.